...Research supplier Bio-Techne will acquire ProteinSimple for $300 million in cash. ProteinSimple develops and commercializes proprietary... ...product line. ProteinSimple will continue as a division of Bio-Techne and will be led by ProteinSimple... ...ended March 31. ProteinSimple reported revenues of $57.1 million for the year ended March 31. ProteinSimple...
ProteinSimple , Santa Clara, Calif. Business: Proteomics, Diagnostic Date announced: 5/1/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: JPMorgan; BofA Merrill Lynch; Cowen; Leerink Partners Note: The company is...
...Tool company ProteinSimple (Santa Clara, Calif.) filed to raise up to $86.3 million in an IPO... ...an IPO on NASDAQ underwritten by JPMorgan; BofA Merrill Lynch; Cowen; and Leerink. ProteinSimple (formerly Cell Biosciences...
...Convergent markets its iCE280 system for whole column detection capillary isoelectric focusing (cIEF). According to Cell Biosciences... ...of about $8 million. The deal is expected to close by the end of October. Cell Biosciences...
...Research supplier Bio-Techne will acquire ProteinSimple for $300 million in cash. ProteinSimple develops and commercializes proprietary... ...product line. ProteinSimple will continue as a division of Bio-Techne and will be led by ProteinSimple... ...ended March 31. ProteinSimple reported revenues of $57.1 million for the year ended March 31. ProteinSimple...
ProteinSimple , Santa Clara, Calif. Business: Proteomics, Diagnostic Date announced: 5/1/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: JPMorgan; BofA Merrill Lynch; Cowen; Leerink Partners Note: The company is...
...Tool company ProteinSimple (Santa Clara, Calif.) filed to raise up to $86.3 million in an IPO... ...an IPO on NASDAQ underwritten by JPMorgan; BofA Merrill Lynch; Cowen; and Leerink. ProteinSimple (formerly Cell Biosciences...
...Convergent markets its iCE280 system for whole column detection capillary isoelectric focusing (cIEF). According to Cell Biosciences... ...of about $8 million. The deal is expected to close by the end of October. Cell Biosciences...